Condition: Alcoholic Hepatitis · Sponsor: Bioaraba Health Research Institute
This study is designed to evaluate the hypothesis that patients with severe acute alcoholic hepatitis have lower morbi-mortality if the patients receive treatment with corticosteroids + NAC, compared to patients that only receive corticosteroids.
This description comes directly from the study's public registry record.
Ana Belén Fernández, Clinic · 945007000 · anabelen.fernandezlaso@osakidetza.eus
Inés Pérez, Coordinator · 945007000 · ines.perezfrancisco@osakidetza.eus
Always discuss trial participation with your own doctor first.
| Ana Belén Fernández Laso | Vitoria-Gasteiz, Álava, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05294744